Physician profile
Lawrence Friedman
NPI 1972571990
$6,845.36
in general payments reported to CMS, 2019-2025
52 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $490 · 2021: $720 · 2022: $1,155 · 2023: $1,195 · 2024: $1,184 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,492.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,092.67 | 2019-2023 | Myrbetriq, Veozah |
| Pfizer INC. | $813.18 | 2019-2025 | |
| Janssen Biotech, INC. | $561.11 | 2019-2025 | Erleada, Akeega, Balversa |
| Bayer Healthcare Pharmaceuticals INC. | $415.37 | 2019-2025 | |
| Abbvie INC. | $402.88 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $336.07 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $271.75 | 2022-2023 | Aquabeam Robotic System |
| Merck Sharp & Dohme LLC | $238.78 | 2021-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $238.08 | 2021-2025 | Lynparza |
| Endo Pharmaceuticals INC. | $235.52 | 2019-2024 | Xiaflex, Aveed |
| Dendreon Pharmaceuticals LLC | $168.92 | 2019-2025 | Provenge |
| Sun Pharmaceutical Industries INC. | $149.87 | 2021-2025 | |
| Urovant Sciences INC | $128.38 | 2021-2022 | |
| 180 Medical, INC. | $127.98 | 2019-2024 | |
| Telix Pharmaceuticals | $126.33 | 2023-2025 | Illuccix |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.